D.E. Shaw & Co
SWAV

D.E. Shaw & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

D.E. Shaw & Co’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,500
Closed -$5.05M – 4849
2023
Q4 		$5.05M Hold
26,500
– – ﹤0.01% 1896
2023
Q3 		$5.28M Hold
26,500
– – 0.01% 1766
2023
Q2 		$7.56M Buy
26,500
+11,300
+74% +$3.14M 0.01% 1567
2023
Q1 		$3.3M Sell
15,200
-7,400
-33% -$1.44M ﹤0.01% 2305
2022
Q4 		$4.65M Hold
22,600
– – 0.01% 2168
2022
Q3 		$6.28M Buy
+22,600
New +$5.75M 0.01% 1824
2022
Q2 		– Sell
-2,200
Closed -$456K – 5901
2022
Q1 		$456K Sell
2,200
-20,000
-90% -$3.3M ﹤0.01% 4426
2021
Q4 		$3.96M Buy
22,200
+12,200
+122% +$2.41M ﹤0.01% 2646
2021
Q3 		$2.06M Buy
10,000
+7,000
+233% +$1.37M ﹤0.01% 3013
2021
Q2 		$569K Sell
3,000
-4,800
-62% -$786K ﹤0.01% 3966
2021
Q1 		$1.02M Buy
+7,800
New +$936K ﹤0.01% 3095

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

D.E. Shaw & Co's SWAV Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,617 shares — an estimated $397K sold.

D.E. Shaw & Co first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $38.8M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,617 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $397K.
  • D.E. Shaw & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • D.E. Shaw & Co's Shockwave Medical, Inc. Common Stock position peaked at $38.8M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.